SCHEMBL5622935

SCHEMBL5622935

COc1ccc(N(CC(F)(F)F)S(=O)(=O)c2ccc(OC)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.61
NFE2L2 Q16236 1/20 0.61
RORC P51449 6/20 0.59
NR1I2 O75469 10/20 0.57
RORA P35398 3/20 0.57
RORB Q92753 3/20 0.57
NR1H4 Q96RI1 3/20 0.57
NR1H2 P55055 4/20 0.56
NR1H3 Q13133 2/20 0.56
ALDH1A1 P00352 4/20 0.54
LMNA P02545 2/20 0.54
NR3C1 P04150 1/20 0.54
PGR P06401 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
MAPT P10636 1/20 0.52
RXRA P19793 1/20 0.52
SREBF1 P36956 1/20 0.52
PSEN1 P49768 1/20 0.52
PSEN2 P49810 1/20 0.52
NR1I3 Q14994 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5622256 0.85 ESR1 (0.68) KEAP1NFE2L2RORCNR1H2ALDH1A1
SCHEMBL28467162 0.83 ESR1 (0.46) KEAP1NFE2L2RORCNR1I2RORA
SCHEMBL5622498 0.81 KEAP1 (0.68) KEAP1NFE2L2ALDH1A1LMNANR3C1
SCHEMBL5623558 0.80 ESR1 (0.72) RORCNR1I2RORARORBNR1H4
SCHEMBL28426841 0.79 APLNR (0.51) KEAP1NFE2L2RORCNR1I2RORA
SCHEMBL6962920 0.78 NR3C1 (0.68) KEAP1NFE2L2ALDH1A1LMNANR3C1
SCHEMBL5622632 0.78 KEAP1 (0.64) KEAP1NFE2L2ALDH1A1LMNANR3C1
SCHEMBL5623334 0.77 KEAP1 (0.62) KEAP1NFE2L2RORCNR1H2ALDH1A1
SCHEMBL1631020 0.76 KEAP1 (0.87) KEAP1NFE2L2
SCHEMBL1630208 0.76 KEAP1 (0.81) KEAP1NFE2L2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021495-A1 SULFONAMIDES AS SELECTIVE ESTROGEN RECEPTOR NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021495-A1 SULFONAMIDES AS SELECTIVE ESTROGEN RECEPTOR ESR1, ESR2, GPER1 KEAP1 2322/4885NFE2L2 791/4885RORC 250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.